Partnering Culture
Partnering Culture
Search
The Research Process
Science and Innovation - Animal Health Innovation - Parasiticides
Parasiticides
Science and Innovation - Animal Health Innovation - Parasiticides
Therapeutics
Science and Innovation - Animal Health Innovation - Therapeutics
Vaccines
Science and Innovation - Animal Health Innovation - Vaccines
Meet our Team
Find all our contact information here as well as information on where you can meet us virtually or in person. You can also find out how to submit your opportunity to our BD&L team
Partnering
Partnering
Scleroderma
Systemic sclerosis is a complex rare disease with a variable course. It presents with a range of symptoms involving several different organs
More Green
More Green
COPD & Asthma
COPD & Asthma
Pulmonary Fibrosis
Pulmonary Fibrosis
University of Saskatchewan’s Dr. Diego Moya named 2024 Metacam® Bovine Welfare Award winner
Award recognizes outstanding contributions to advancing animal welfare in Canada
Heart Diseases
Heart Diseases
Human Health Partnering Connect with Us
Human Health Partnering Connect with Us
Patient Centricity
Patient Centricity
Corporate profile
Corporate profile
Data Privacy
Data Privacy
Heart Failure
Heart Failure
Sustainable Development - Our Commitment
Our Commitment
Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER-IPF study
Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER-IPF™ study
Explore our company
Make your next career step at Boehringer Ingelheim. Explore our various fields to find out more about employment opportunities in your area of interest.
Borderline Personality Disorder
Borderline Personality Disorder
Media Overview
Media Overview
Partnering at Boehringer Ingelheim Canada
Partnering at Boehringer Ingelheim Canada
Science Focus
Science and Innovation - Human Health Innovation - Science Focus